Thyroid hormone levels in children with Prader-Willi Syndrome: A randomized controlled Growth Hormone (GH)-trial and 10-year GH study.
Demi J Trueba-TimmermansLionne N GrootjenGerthe F KerkhofEdmond H H M RingsAnita C S Hokken-KoelegaPublished in: European journal of endocrinology (2024)
Our findings suggest that GH-treatment decreases FT4 levels, due to increased peripheral conversion of FT4 to T3 in the first months of treatment, but thereafter FT4 and T3 normalize and remain stable during long-term GH-treatment in almost all children and adolescents with PWS.
Keyphrases